Medicare coverage will cut obesity-drug prices but open the door to millions of new patients.

Below, doctors explain everything you need to know about the phenomenon. It’s important to be clear upfront that “Ozempic ...

Trump administration drug deals link U.S. prices to global lows, aiming to cut costs via Pfizer, AstraZeneca, and TrumpRx in 2026.

Pfizer won its fight to buy obesity-drug maker Metsera, with an extra $1.7 billion and a little help from the Trump administration. Pfizer Inc. pulled off a comeback win, beating out Danish drug giant ...

As can dietary fibers. A systematic review and meta-analysis published in September 2025 found that dietary fiber supplements ...

New versions of drugs like Wegovy, Ozempic, Mounjaro and Zepbound, including pills, will be easier to take, more effective ...

Three new Cochrane reviews find evidence that GLP-1 drugs lead to clinically meaningful weight loss, though industry-funded ...

Savannah Chrisley shared that she plans to begin using a GLP-1 medication to help her lose 25 pounds after previously trying ...

Economist Emily Oster joins Michael Smerconish to discuss the growing debate over whether Medicare and Medicaid should cover GLP-1 weight-loss drugs like Ozempic. With prices dropping and evidence ...

Pfizer has signed a deal to purchase Metsera Inc., an obesity drugmaker in the development stage, after winning a bidding war ...

Hope is on the horizon for some people with dementia. According to Statista, “In 2020, it was estimated that around 9.7 per ...

Ever watchful, skincare brands are eyeing their new frontier. Early pioneers—three, to be exact—have formulated serums to ...